Related references
Note: Only part of the references are listed.Pulmonary nodule volumetric measurement variability as a function of CT slice thickness and nodule morphology
Myria Petrou et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Integrated PET-CT for the characterization of adrenal gland lesions in cancer patients: Diagnostic efficacy and interpretation pitfalls
Semin Chong et al.
RADIOGRAPHICS (2006)
Monitoring tumor glucose utilization by positron emission tomography for the prediction of treatment response to epidermal growth factor receptor kinase inhibitors
Helen Su et al.
CLINICAL CANCER RESEARCH (2006)
Current standards for response evaluation by imaging techniques
S. J. Gwyther
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
RECIST revisited: A review of validation studies on tumour assessment
P. Therasse et al.
EUROPEAN JOURNAL OF CANCER (2006)
Adenocarcinomas of esophagogastric junction: Multi-detector row CT to evaluate early response to neoadjuvant chemotherapy
AJ Beer et al.
RADIOLOGY (2006)
CT of colon cancer metastases to the liver using modified RECIST criteria: Determining the ideal number of target lesions to measure
TT Zacharia et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2006)
Morphological segmentation and partial volume analysis for volumetry of solid pulmonary lesions in thoracic CT scans
JM Kuhnigk et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2006)
Multi-tracer small animal PET imaging of the tumour response to the novel pan-Erb-B inhibitor CI-1033
DS Dorow et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases
B Tombal et al.
PROSTATE (2005)
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
N Thatcher et al.
LANCET (2005)
Objective responses in patients with malignant melanoma or renal cell cancer in early clinical studies do not predict regulatory approval
J Goffin et al.
CLINICAL CANCER RESEARCH (2005)
Objective response to chemotherapy as a potential surrogate end point of survival in metastatic breast cancer patients
P Bruzzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Erlotinib in previously treated non-small-cell lung cancer
FA Shepherd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
RECIST vs. WHO:: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma
P Therasse et al.
EUROPEAN JOURNAL OF CANCER (2005)
Gastrointestinal stromal tumor: New nodule-within-a-mass pattern of recurrence after partial response to imatinib mesylate
S Shankar et al.
RADIOLOGY (2005)
Informatics in radiology (infoRAD) -: New tools for computer assistance in thoracic CT -: Part 2.: Therapy monitoring of pulmonary metastases
L Bornemann et al.
RADIOGRAPHICS (2005)
A theoretical approach to choosing the minimum number of multiple tumors required for assessing treatment response
M Mazumdar et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2005)
A statistical simulation study finds discordance between WHO criteria and RECIST guideline
M Mazumdar et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2004)
Adrenal masses: MR imaging features with pathologic correlation
KM Elsayes et al.
RADIOGRAPHICS (2004)
Bone imaging in metastatic breast cancer
T Hamaoka et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography
LN Tran et al.
ACADEMIC RADIOLOGY (2004)
Are two-dimensional CT measurements of small noncalcified pulmonary nodules reliable?
MP Revel et al.
RADIOLOGY (2004)
Effect of varying CT section width on volumetric measurement of lung tumors and application of compensatory equations
HT Winer-Muram et al.
RADIOLOGY (2003)
Tumour size measurement in an oncology clinical trial: Comparison between off-site and on-site measurements
AL Belton et al.
CLINICAL RADIOLOGY (2003)
The price of innovation: new estimates of drug development costs
JA DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2003)
The role of functional and molecular imaging in cancer drug discovery and development
BM Seddon et al.
BRITISH JOURNAL OF RADIOLOGY (2003)
CT tumor measurement for therapeutic response assessment: Comparison of unidimensional, bidimensional, and volumetric techniques - Initial observations
SR Prasad et al.
RADIOLOGY (2002)
Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma
JD Bradley et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Comparison of one-, two-, and three-dimensional measurements of childhood brain tumors
KE Warren et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size
SA Sohaib et al.
BRITISH JOURNAL OF RADIOLOGY (2000)
Small pulmonary nodules: Volumetrically determined growth rates based on CT evaluation
DF Yankelevitz et al.
RADIOLOGY (2000)
Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis
M Buyse et al.
LANCET (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
